Chronic kidney disease (CKD) is on the rise, and developing artificial kidneys from scratch could save millions of lives ...

SAN DIEGO -- There was a clinically meaningful reduction in proteinuria with iptacopan (Fabhalta), and a confirmed clinical ...

The 43 patients treated with ravulizumab had a 33.2% greater reduction in average urine protein to creatinine ratio (UPCR) ...

▲ 点击上方蓝字关注CellPress细胞科学 ▲生命科学Life scienceTrends in Molecular Medicine是Cell ...

The FDA has approved Orlynvah, a new oral treatment for uncomplicated urinary tract infections (UTIs) in women who have limited options for effective antibiotic therapy.

During the trial, patients treated with Fabhalta experienced a significant reduction in proteinuria as early as two weeks.

The cost of dialysis care is one of the leading medical expenditures of the federal government. This Canton startup is trying ...

As we start looking to the year ahead, the pharma industry is gearing up for a slate of new drug launches and U.S. Food and ...

C3G is estimated to affect around one person per million in the US, a small patient population, but is one of a series of ...

An FDA advisory committee voted Thursday that it didn’t believe the benefits of Lexicon's (LXRX) diabetes drug sotagliflozin ...